Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Journal of Chemical Information and Modeling
|
December 8, 2009
GPU accelerated support vector machines for mining high-throughput screening data
Quan Liao, Jibo Wang, Yue Webster, et al.
Journal of Medicinal Chemistry
|
October 2, 2009
Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches
Michal Vieth, Jon Erickson, Jibo Wang, et al.
Drug Discovery Today
|
March 16, 2011
The role of translational bioinformatics in drug discovery
Natalie S Buchan, Deepak K Rajpal, Yue Webster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling
Michele Dowless, Caitlin D Lowery, Terry Shackleford, et al.
Cancer Cell
|
September 8, 2015
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
Sheng-Bin Peng, James R Henry, Michael D Kaufman, et al.
Cancer Cell
|
December 13, 2017
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong, Lacey M Litchfield, Yue Webster, et al.
Cancer Discovery
|
October 31, 2018
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene
Xueqian Gong, Jian Du, Stephen H Parsons, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Journal of Chemical Information and Modeling
|
December 8, 2009
GPU accelerated support vector machines for mining high-throughput screening data
Quan Liao, Jibo Wang, Yue Webster, et al.
Journal of Medicinal Chemistry
|
October 2, 2009
Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches
Michal Vieth, Jon Erickson, Jibo Wang, et al.
Drug Discovery Today
|
March 16, 2011
The role of translational bioinformatics in drug discovery
Natalie S Buchan, Deepak K Rajpal, Yue Webster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling
Michele Dowless, Caitlin D Lowery, Terry Shackleford, et al.
Cancer Cell
|
September 8, 2015
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
Sheng-Bin Peng, James R Henry, Michael D Kaufman, et al.
Cancer Cell
|
December 13, 2017
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong, Lacey M Litchfield, Yue Webster, et al.
Cancer Discovery
|
October 31, 2018
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene
Xueqian Gong, Jian Du, Stephen H Parsons, et al.
Page
of 1